Invesco Biotechnology & Genome ETF (PBE) Holdings $63.94 -0.81 (-1.25%) As of 06/13/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Top 33 PBE HoldingsRankCompanyCurrent PriceWeightShares Held1NBIXNeurocrine Biosciences$124.39-0.5%5.60%101,9072NTRANatera$165.34+0.6%5.30%75,7113GILDGilead Sciences$109.98-1.8%5.20%105,9044BIIBBiogen$130.65-1.3%4.73%82,3265AMGNAmgen$295.22-0.7%4.65%37,4186UTHRUnited Therapeutics$283.35-1.0%4.65%33,0427ILMNIllumina$86.93-1.4%4.53%123,3478REGNRegeneron Pharmaceuticals$529.24+1.4%4.39%16,3279PTGXProtagonist Therapeutics$56.37+0.1%3.83%183,59410BCRXBioCryst Pharmaceuticals$10.37-0.3%3.76%777,314 Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 11TGTXTG Therapeutics$36.01-3.6%3.48%220,55712CPRXCatalyst Pharmaceuticals$23.53-3.1%3.47%309,73213ACADACADIA Pharmaceuticals$21.71-0.1%3.40%338,56314EXELExelixis$41.59-0.5%3.38%174,34515EXASExact Sciences$53.52-0.9%3.34%128,25816BPMCBlueprint Medicines$127.96-0.2%3.27%70,60017QGENQiagen$47.08-0.7%3.12%162,13218COLLCollegium Pharmaceutical$29.18-1.4%2.95%223,54619RPRXRoyalty Pharma$34.84-1.2%2.83%191,05120HALOHalozyme Therapeutics$53.98-1.0%2.77%111,09421PTCTPTC Therapeutics$51.26+0.5%2.69%127,93322INCYIncyte$67.75-2.1%2.54%86,49823CDNACareDx$18.59-1.3%2.39%308,09424VCYTVeracyte$26.44-0.9%2.39%192,36325BMRNBioMarin Pharmaceutical$56.22-1.9%2.38%90,44526DVAXDynavax Technologies$10.27-1.3%2.15%479,99327TECHBio-Techne$50.52-2.0%2.14%100,22428MNKDMannKind$3.71-3.1%2.14%1,139,14829XNCRXencor$9.19-2.5%1.54%445,41530MYGNMyriad Genetics$5.03-3.1%0.98%548,16931Short-Term Investment Trust - Invesco Government & Agency PortfolioN/A0.02%46,77632CashN/A0.00%5,72833Securities Lending - BnymN/A0.00%1 Geographic ExposureUnited States97.2%Netherlands2.9%Currency ExposureUSD100.1%Sector ExposureHealth Care97.1%Materials2.9%Industry ExposureBiotechnology84.1%Health Care Equipment & Supplies13.0%Metals & Mining2.9%SubIndustry ExposureBiotechnology84.1%Life Sciences Tools & Services10.2%Diversified Metals & Mining2.9%Health Care Equipment2.8%Coupon Exposure4-60.1% Related Companies and Tools Related Companies Invesco Pharmaceuticals ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio SPDR S&P Pharmaceuticals ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio Direxion Daily Healthcare Bull 3x Shares Portfolio Simplify Health Care ETF Portfolio VanEck Biotech ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio KraneShares MSCI All China Health Care Index ETF Portfolio SPDR S&P Health Care Services ETF Portfolio This page (NYSEARCA:PBE) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PBE Stock Free PBE Stock Alerts